MLab has secured new growth funding from GENEO Capital Entrepreneur and co-investors to enhance its capital structure and support future acquisitions while committing to positive impact initiatives.

Target Information

MLab, founded in 1995 by Dr. Michel Lhuillier and driven by Dr. Frank Mentz, is a leading independent medical biology group in France, exclusively owned by practicing biologists. With a strong regional presence in Paris and 11 departments, MLab operates 75 laboratories under seven brands, including Bio+, CBSV, and Medi+. Each day, the group processes approximately 8,500 patient files, supported by over 850 employees and nine technical platforms functioning 24/7. All facilities are accredited under NF EN ISO 15189 standards and collaborate with several medical-surgical clinics and a public hospital, backed by their specialized analysis laboratory, BPR.

Industry Overview

The medical biology sector in France is characterized by a network of independent laboratories serving a diverse range of diagnostic needs. This industry is undergoing consolidation, driven by the increasing demand for specialized tests and the need for improved operational efficiencies. The market has seen a trend towards the integration of technological advancements aimed at enhancing laboratory productivity and diagnostic accuracy.

In recent years, governmental policies have emphasized the importance of healthcare accessibility, increasing funding for medical laboratories. This attention to infrastru